Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesOutcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy
Annals of Oncology, 11/16/09
Radaideh SM et al. – The presence of rising STM doesn't preclude successful therapy with surgical resection, especially if carried out by experienced thoracic surgical oncologists.
Related Articles
Metachronous bilateral testicular germ cell tumors: Report of two cases
Journal of Cancer Research and Therapeutics, 10/28/09
Relevance Score: 69%
Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma
Human Pathology, 10/22/09
Relevance Score: 69%
Clinicopathological Study of Regressed Testicular Tumors (Apparent Extragonadal Germ Cell Neoplasms)
The Journal of Urology, 10/22/09
Relevance Score: 68%
Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases
Modern Pathology, 10/13/09
Relevance Score: 68%
Male germ cell development: turning on the apoptotic pathways
Journal of Reproductive Immunology, 11/05/09
Relevance Score: 66%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Anticancer effects of CAMEL peptide
Laboratory Investigation, 03/19/10
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
British Journal of Haematology, 03/19/10
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/19/10
Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets
Laboratory Investigation, 03/19/10
Article Search
Sponsor
Sponsor